A comprehensive review of arginine kinase proteins: What we need to know?

被引:1
|
作者
Vasconcellos, Brenda Martins [1 ]
Ribeiro, Victor Guimaraes [1 ]
Campos, Naysha do Nascimento [1 ]
Roma Mota, Luis Guilherme da Silva [1 ]
Moreira, Monica Ferreira [1 ,2 ]
机构
[1] Univ Fed Rio Janeiro, Inst Quim, BR-21941909 Rio De Janeiro, RJ, Brazil
[2] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil
关键词
Arginine kinase enzyme; Insect; Phosphoarginine; AMINO-ACID-SEQUENCE; TRYPANOSOMA-CRUZI; PHOSPHAGEN KINASE; CRYSTAL-STRUCTURE; HELICOVERPA-ARMIGERA; ALLERGENIC PROTEINS; COCKROACH ALLERGEN; TOXOCARA-CANIS; LOBSTER MUSCLE; EVOLUTION;
D O I
10.1016/j.bbrep.2024.101837
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme arginine kinase (AK), EC 2.7.3.3, catalyzes the reversible phosphorylation of arginine with adenosine triphosphate, forming phosphoarginine, which acts as an energy reservoir due to its high-energy phosphate content that can be rapidly transferred to ADP for ATP renewal. It has been proposed that AK should be associated with some ATP biosynthesis mechanisms, such as glycolysis and oxidative phosphorylation. Arginine kinase is an analogue of creatine kinase found in vertebrates. A literature survey has recovered the physicochemical and structural characteristics of AK. This enzyme is widely distributed in invertebrates such as protozoa, bacteria, porifera, cnidaria, mollusca, and arthropods. Arginine kinase may be involved in the response to abiotic and biotic stresses, being up regulated in several organisms and controlling energy homeostasis during environmental changes. Additionally, phosphoarginine plays a role in providing energy for the transport of protozoa, the beating of cilia, and flagellar movement, processes that demand continuous energy. Arginine kinase is also associated with allergies to shellfish and arthropods, such as shrimp, oysters, and cockroaches. Phenolic compounds such as resveratrol, which decrease AK activity by 50 % in Trypanosoma cruzi, inhibit the growth of the epimastigote and trypomastigote forms, making them a significant target for the development of medications for Chagas Disease treatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Sexual selection and environmental change: what do we know and what comes next?
    Pilakouta, Natalie
    Alund, Murielle
    CURRENT ZOOLOGY, 2021, 67 (03) : 293 - 298
  • [32] What we know and don't know about great ape cultural communication in the wild
    Kalan, Ammie K.
    Nakano, Robyn
    Warshawski, Lindsey
    AMERICAN JOURNAL OF PRIMATOLOGY, 2025, 87 (01)
  • [33] Weedy Rice Infestation in Malaysia: What Do We Know and Where Do We Go?
    Mahmod, Intan Filzah
    Bakar, Sharifah Nurnabilah Syed
    Mispan, Muhamad Shakirin
    Supandi, Farahaniza
    Mohamed, Zulqarnain
    Saiman, Mohd Zuwairi
    AGRICULTURE-BASEL, 2024, 14 (08):
  • [34] Agnotology: How can we handle what we don't know in a knowing way?
    Weiss, Kenneth M.
    EVOLUTIONARY ANTHROPOLOGY, 2012, 21 (03): : 96 - 100
  • [35] What do we know about hybridization among bryophytes in nature?
    Natcheva, R
    Cronberg, N
    CANADIAN JOURNAL OF BOTANY-REVUE CANADIENNE DE BOTANIQUE, 2004, 82 (12): : 1687 - 1704
  • [36] What Do We Know about Chagas Disease in the United States?
    Montgomery, Susan P.
    Parise, Monica E.
    Dotson, Ellen M.
    Bialek, Stephanie R.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (06): : 1225 - 1227
  • [37] Chagas Disease Chemotherapy: What Do We Know So Far?
    Zuma, Aline A.
    de Souza, Wanderley
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (38) : 3963 - 3995
  • [38] Agricultural GMOs-What We Know and Where Scientists Disagree
    Zilberman, David
    Holland, Tim G.
    Trilnick, Itai
    SUSTAINABILITY, 2018, 10 (05)
  • [39] Genetics and Epigenetics in Obesity: What Do We Know so Far?
    Keller, Maria
    Svensson, Stina Ingrid Alice
    Rohde-Zimmermann, Kerstin
    Kovacs, Peter
    Boettcher, Yvonne
    CURRENT OBESITY REPORTS, 2023, 12 (04): : 482 - 501